Morreau Jane Cecil 4
4 · Trulieve Cannabis Corp. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Trulieve (TRUL) Director Morreau Jane Cecil Receives RSU Award
What Happened Morreau Jane Cecil, a director of Trulieve Cannabis Corp. (TRUL), received a grant of 23,438 restricted stock units (RSUs) on March 13, 2026. The award was reported as an acquisition (transaction code A) at $0.00 paid—these are contingent rights to receive one Trulieve subordinate voting share per RSU rather than an open-market purchase.
Key Details
- Transaction date: 2026-03-13; Form 4 filed 2026-03-17 (timely filed).
- Award: 23,438 RSUs; reported acquisition price $0.00 (no cash exchanged).
- Shares owned after transaction: Not disclosed on the Form 4.
- Footnote: RSUs vest on the earliest of (i) end of the reporting person's board service, (ii) a change of control, or (iii) December 1, 2032.
- Transaction code: A = Award/Grant.
Context This is a grant of equity compensation (RSUs), not a market purchase or sale, so it does not directly signal trading sentiment. RSUs convert to actual shares only upon vesting under the conditions above. No tax-withholding or sale-on-vesting details were reported in this filing.
Insider Transaction Report
- Award
Subordinate Voting Shares
[F1]2026-03-13+23,438→ 65,778 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2032.